| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/nar/KoesC12a |
| P356 | DOI | 10.1093/NAR/GKS378 |
| P932 | PMC publication ID | 3394271 |
| P698 | PubMed publication ID | 22553363 |
| P5875 | ResearchGate publication ID | 224889091 |
| P2093 | author name string | Carlos J Camacho | |
| David Ryan Koes | |||
| P2860 | cites work | A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application. | Q51919227 |
| Comparative performance assessment of the conformational model generators omega and catalyst: a large-scale survey on the retrieval of protein-bound ligand conformations. | Q51936967 | ||
| A web-based 3D-database pharmacophore searching tool for drug discovery | Q77814709 | ||
| Open Babel: An open chemical toolbox | Q21198766 | ||
| ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
| 3-D pharmacophores in drug discovery | Q30670909 | ||
| Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. | Q30780748 | ||
| Library design and virtual screening using multiple 4-point pharmacophore fingerprints | Q30886512 | ||
| LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters | Q31143138 | ||
| EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities | Q33738554 | ||
| Pharmer: efficient and exact pharmacophore search | Q33909006 | ||
| Swimming into peptidomimetic chemical space using pepMMsMIMIC. | Q33915436 | ||
| PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach | Q33957682 | ||
| Small-molecule inhibitor starting points learned from protein-protein interaction inhibitor structure | Q34115282 | ||
| Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
| Maximum common subgraph isomorphism algorithms for the matching of chemical structures | Q35037939 | ||
| Why do we need so many chemical similarity search methods? | Q35053182 | ||
| PharmaGist: a webserver for ligand-based pharmacophore detection | Q36749332 | ||
| Molecule-pharmacophore superpositioning and pattern matching in computational drug design | Q37055387 | ||
| Three-dimensional pharmacophore methods in drug discovery | Q37615315 | ||
| One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space | Q43469957 | ||
| Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations | Q45166891 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | Web Server issue | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | database | Q8513 |
| ZINC database | Q8063109 | ||
| P304 | page(s) | W409-14 | |
| P577 | publication date | 2012-05-02 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | ZINCPharmer: pharmacophore search of the ZINC database | |
| P478 | volume | 40 |
| Q51094113 | 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. |
| Q30009284 | A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region |
| Q60218432 | A Hybrid Structure/Pharmacophore-Based Virtual Screening Approach to Design Potential Leads: A Computer-Aided Design of South African HIV-1 Subtype C Protease Inhibitors |
| Q28547139 | A Teach-Discover-Treat Application of ZincPharmer: An Online Interactive Pharmacophore Modeling and Virtual Screening Tool |
| Q33860664 | A multi-fingerprint browser for the ZINC database |
| Q55432485 | A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model. |
| Q38796994 | A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential |
| Q90619451 | All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening |
| Q47111998 | An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors |
| Q95839233 | An RNA-dependent RNA polymerase inhibitor for tick-borne encephalitis virus |
| Q90194262 | Application of the SwissDrugDesign Online Resources in Virtual Screening |
| Q49986235 | Better agonist for the opioid receptors. |
| Q36554718 | Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 Experiment |
| Q62674529 | Cloud-Based High Throughput Virtual Screening in Novel Drug Discovery |
| Q35529213 | Combining spatial and chemical information for clustering pharmacophores |
| Q38973232 | Computational Methods Applied to Rational Drug Design. |
| Q93185208 | Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy |
| Q91901077 | Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant |
| Q92703022 | Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening |
| Q90042467 | Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy |
| Q26795719 | Focusing on shared subpockets - new developments in fragment-based drug discovery |
| Q46213251 | Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs |
| Q28548496 | Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening |
| Q36226323 | Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs. |
| Q92642058 | Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening |
| Q40680044 | Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling |
| Q49804173 | Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening. |
| Q47885052 | Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies. |
| Q39115190 | Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs |
| Q46010015 | Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations. |
| Q89152321 | Improving small molecule virtual screening strategies for the next generation of therapeutics |
| Q38958882 | In Silico Discovery and In Vitro Validation of Catechol-Containing Sulfonohydrazide Compounds as Potent Inhibitors of the Diguanylate Cyclase PleD |
| Q52682510 | In silico and crystallographic studies identify key structural features of biliverdin IXβ reductase inhibitors having nanomolar potency. |
| Q34357512 | In silico models for predicting vector control chemicals targeting Aedes aegypti |
| Q28539353 | Inhibitor ranking through QM based chelation calculations for virtual screening of HIV-1 RNase H inhibition |
| Q38866178 | Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites. |
| Q35156844 | Integrated computational tools for identification of CCR5 antagonists as potential HIV-1 entry inhibitors: homology modeling, virtual screening, molecular dynamics simulations and 3D QSAR analysis. |
| Q92238012 | Machine Learning From Molecular Dynamics Trajectories to Predict Caspase-8 Inhibitors Against Alzheimer's Disease |
| Q35535762 | Novel PDE4 inhibitors derived from Chinese medicine forsythia |
| Q42691078 | Optimal affinity ranking for automated virtual screening validated in prospective D3R grand challenges. |
| Q36116506 | Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge |
| Q35999174 | Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents |
| Q38804026 | PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database |
| Q37682063 | Pharmacophore and Virtual Screening of JAK3 inhibitors |
| Q39008696 | Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors. |
| Q28830087 | Pharmit: interactive exploration of chemical space |
| Q90430431 | Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations |
| Q60305725 | Predicting protein targets for drug-like compounds using transcriptomics |
| Q99575411 | Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach |
| Q47561431 | Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease. |
| Q40080477 | Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors |
| Q37101562 | Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1. |
| Q40611780 | Screening of potential targets in Plasmodium falciparum using stage-specific metabolic network analysis |
| Q35860552 | Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b5 Reductase 3 That Increase Nitric Oxide Bioavailability |
| Q92126621 | Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Multicomponent Reactions and In Vitro-In Silico Studies Against SiHa, HeLa, and CaSki Human Cervical Carcinoma Cell Lines |
| Q47137879 | Targeting SxIP-EB1 interaction: An integrated approach to the discovery of small molecule modulators of dynamic binding sites. |
| Q88163980 | The forecast of anticancer targets of cryptotanshinone based on reverse pharmacophore-based screening technology |
| Q57070027 | Using bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors |
| Q59223627 | Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands |
| Q46337247 | Virtual screening and statistical analysis in the design of new caffeine analogues molecules with potential epithelial anticancer activity |
| Q28607096 | ZINC 15--Ligand Discovery for Everyone |
| Q29965894 | Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery |
| Q58596849 | ezCADD: A Rapid 2D/3D Visualization Enabled Web Modeling Environment for Democratizing Computer-Aided Drug Design |
| Q33712915 | iDrug: a web-accessible and interactive drug discovery and design platform |
Search more.